Kelleher Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,135
Closed -$378K 110
2020
Q1
$378K Hold
2,135
0.45% 51
2019
Q4
$408K Sell
2,135
-47
-2% -$8.48K 0.41% 61
2019
Q3
$367K Sell
2,182
-179
-8% -$29.2K 0.45% 57
2019
Q2
$395K Buy
+2,361
New +$327K 0.49% 53
2018
Q4
$258K Sell
1,933
-100
-5% -$16.4K 0.41% 67
2018
Q3
$387K Buy
2,033
+26
+1% +$4.78K 0.5% 50
2018
Q2
$335K Buy
2,007
+5
+0.2% +$803 0.48% 56
2018
Q1
$337K Buy
2,002
+105
+6% +$17.6K 0.46% 56
2017
Q4
$310K Sell
1,897
-21
-1% -$3.77K 0.49% 60
2017
Q3
$393K Sell
1,918
-110
-5% -$25.6K 0.83% 42
2017
Q2
$493K Sell
2,028
-48
-2% -$11.3K 0.95% 36
2017
Q1
$496K Buy
2,076
+81
+4% +$18.9K 1.06% 30
2016
Q4
$419K Buy
1,995
+330
+20% +$68.4K 0.23% 87
2016
Q3
$383K Hold
1,665
0.22% 88
2016
Q2
$385K Sell
1,665
-256
-13% -$59K 0.23% 83
2016
Q1
$514K Buy
+1,921
New +$550K 0.28% 83

Other funds holding AGN

Kelleher Financial Advisors's AGN Position: Q2 2020 in Review

Kelleher Financial Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,135 shares — an estimated $378K sold.

Kelleher Financial Advisors first reported a position in AGN in Q1 2016 and held it in 16 quarters. The position peaked at $514K in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Kelleher Financial Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Kelleher Financial Advisors sold 2,135 Allergan plc shares in Q2 2020, an estimated $378K.
  • Kelleher Financial Advisors first reported a position in Allergan plc in Q1 2016 and held it in 16 quarters.
  • Kelleher Financial Advisors's Allergan plc position peaked at $514K in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Kelleher Financial Advisors's 13F filing for Q2 2020, filed 2 Nov 2021.